Status:
COMPLETED
Comparision of Motor Seizure Duration of Ketofol and Propofol for Electroconvulsive Therapy
Lead Sponsor:
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Conditions:
Electroconvulsive Therapy
Eligibility:
All Genders
16-65 years
Phase:
NA
Brief Summary
Propofol is routinely used in our hospital for ECT. It causes hypotension and has anticonvulsant actions. Use of ketofol ( 1:1 combination of ketamine and propofol) during ECT can have longer seizure ...
Detailed Description
Electroconvulsive therapy (ECT) is a common treatment method used in severe depression and other psychiatric diseases. Currently, most ECT procedures are carried out with muscle paralysis under genera...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- • All patients scheduled for electroconvulsive therapy irrespective of ECT sessions.
- Patients between 16 to 65 years of age
- Patients with ASA -PS of I and II
- Exclus• Pregnant patients
- Patients with a history of Epilepsy
- Patients taking any anticonvulsant medication
- Patients with a history of substance abuse or dependence
- Patients with a history of any adverse effect to any drugs used during the procedure
- ion Criteria:
- \-
Exclusion
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2021
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT05408000
Start Date
January 1 2021
End Date
June 15 2021
Last Update
June 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Dilip Baral
Kathmandu, Bagmati Province, Nepal